Sakane T, Akizuki M, Taki Y, Yamashita S, Sezaki H, Nadai T
Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan.
J Pharm Pharmacol. 1995 May;47(5):379-81. doi: 10.1111/j.2042-7158.1995.tb05814.x.
To clarify the relationship between the direct transport from the rat nasal cavity to the cerebrospinal fluid (CSF) and the molecular weight of the drug, the transport of fluorescein isothiocyanate-labelled dextran (FD) with various molecular weights was investigated. FDs (average molecular weights 4,400 (FD4); 9,400 (FD10); 18,900 (FD20); 40,500 Da (FD40)) were administered nasally or intravenously to rats, and the concentrations in the plasma and the CSF were measured and compared. None of the FDs were detected in the CSF after intravenous administration. However, FD4, FD10 and FD20 were observed to appear in the CSF after nasal administration, whereas the concentration in the plasma was much lower than that after intravenous administration. FD40 was not detected even after nasal administration. In addition, the concentration of these FDs in the CSF decreased with the increase in the molecular weight of FDs. These findings show that drugs with a molecular weight up to at least 20,000 Da can be directly transported from the nasal cavity to the CSF and that the transport of FDs to the CSF is dependent on their molecular weights.
为阐明从大鼠鼻腔直接运输至脑脊液(CSF)与药物分子量之间的关系,研究了不同分子量的异硫氰酸荧光素标记葡聚糖(FD)的运输情况。将平均分子量分别为4400(FD4)、9400(FD10)、18900(FD20)、40500 Da(FD40)的FD经鼻腔或静脉给予大鼠,并测量和比较血浆及脑脊液中的浓度。静脉给药后,脑脊液中未检测到任何一种FD。然而,鼻腔给药后,观察到FD4、FD10和FD20出现在脑脊液中,而血浆中的浓度远低于静脉给药后。即使鼻腔给药后,FD40也未被检测到。此外,这些FD在脑脊液中的浓度随FD分子量的增加而降低。这些发现表明,分子量至少达20000 Da的药物可从鼻腔直接运输至脑脊液,且FD向脑脊液的运输取决于其分子量。